No association of apolipoprotein epsilon 4 allele with schizophrenia even in cognitively impaired patients

Schizophrenia Research

Volumn 30, Issue 2, 1998, Pages 149-153

  Thibaut, Florence ^c   Coron, Béatrice ^d   Hannequin, Didier ^a   Segard, Laetitia ^d   Martin, Cosette ^b   Dollfus, Sonia ^d   Campion, Dominique ^d   Frebourg, Thierry ^b   Petit, Michel ^d  

^a Univ de Médecine   (France)

^b ROUEN UNIVERSITY HOSPITAL   (France)

^c CHS du Rouvray   (France)

^d NONE

Author keywords

Apolipoprotein E; Cognitive impairment; Schizophrenia

Indexed keywords

APOLIPOPROTEIN E4;

ADULT; ARTICLE; COGNITIVE DEFECT; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SCHIZOPHRENIA;

ADULT; ALLELES; APOLIPOPROTEINS E; CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; COGNITION DISORDERS; FEMALE; GENETIC MARKERS; HUMANS; MALE; MIDDLE AGED; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; WECHSLER SCALES;

EID: 0032502346     PISSN: 09209964     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0920-9964(97)00147-3     Document Type: Article

References (21)

1. Arendt, T., Schindler, C., Bruckner, M.K., Eschrich, K., Bigl, V., Zedlick, D., Marcova, L., 1997. Plastic neuronal remodeling is impaired in patients with Alzheimer's disease carrying apolipoprotein ∈4 allele. J. Neurosci. 17, 516-529.
2. Bickeboller, H., Campion, D., Brice, A., Amouyel, P., Hannequin, D., Didierjean, O., Penet, C., Martin, C., Perez-Tur, J., Michon, A., Dubois, B., Ledoze, F., Thomas-Anterion, C., Pasquier, F., Puel, M., Demonet, J.F., Moreaud, O., Babron, M.C., Meulien, D., Guez, D., Chartier-Harlin, M.C., Frebourg, T., Agid, Y., Martinez, M., Clerget-Darpoux, F., 1996. Apolipoprotein E and Alzheimer disease: genotype specific risks by age and sex. Am. J. Hum. Genet. 60, 439-446.
3. Blesa, R., Adroer, R., Santacruz, P., Ascaso, C., Tolosa, E., Oliva, R., 1996. High apolipoprotein E ∈4 allele frequency in age-related memory decline. Ann. Neurol. 39, 548-551.
4. Boone, D., 1991. Use of the modified WAIS-R with psychiatric inpatients: a caution. Percept. Motor Skills 73, 315-322.
5. Das, H.K., McPherson, J., Brun, G.A.P., Karathanasis, S.K., Breslow, J.L., 1985. Isolation, characterization, and mapping to chromosome 19 of the human apolipoprotein E gene. J. Biol. Chem. 260, 6240-6247.
6. Davidson, M., Haroutunian, V., 1995. Cognitive impairment in geriatric schizophrenic patients. In: Bloom, F.E., Kupfer, D.J. (Eds.), Psychopharmacology: The Fourth Generation of Progress, ch. 123. Raven Press, New York, pp. 1447-1458.
7. Dunkley, G., Rogers, D., 1994. The cognitive impairment of severe psychiatric illness: a clinical study. In: David, A.S., Cutting, J.C. (Eds.), The Neuropsychology of Schizophrenia, ch. 11. Erlbaum Associates, Hillsdale, USA pp. 181-196.
8. Feskens, E.J.M., Havekes, L.M., Kalmijn, S., de Knijff, P., Launer, L.J., Kromhout, D., 1994. Apolipoprotein ∈4 allele and cognitive decline in elderly men. Br. Med. J. 309, 1202-1205.
9. Harrison, P.J., 1995. On the neuropathology of schizophrenia and its dementia: neurodevelopmental, neurodegenerative, or both? Neurodegeneration 4, 1-12.
10. Hixson, J.E., Vernier, D.T., 1990. Restriction isotyping of human apoE by gene amplification and cleavage with HhaI. Lipid Res. 31, 545-548.
11. Jönsson, E., Lannfelt, L., Engvall, B., Sedvall, G., 1996. Lack of association between schizophrenia and the apolipoprotein E epsilon 4 allele. Eur. Arch. Psychiatr. Clin. Neurosci. 246, 182-184.
12. Joober, R., Rouleau, G., Eon, E., Lal, S., Palmour, R., Bloom, D., Labelle, A., Benkelfat, C., 1996. Apolipoprotein E genotype in schizophrenia (letter). Am. J. Med. Genet. 67, 235
13. Meloni, R., Laurent, C., Campion, D., Ben Hadjali, B., Thibaut, F., Dollfus, S., Petit, M., Samolyk, D., Martinez, M., Poirier, M.-F., Mallet, J., 1995. A rare allele of a microsatellite located in the tyrosine hydroxylase gene found in schizophrenic patients. C. R. Acad. Sci. 318, 803-809.
14. Nathan, B.P., Bellosta, S., Sanan, A., Weisgraber, K.H., Mahley, R.W., Pitas, R.E., 1994. Differential effects of apolipoproteins ∈3 and ∈4 on neuronal growth in vitro. Science 264, 850-852.
15. Prohovnik, I., Dwork, A.J., Kaufman, M.A., Willson, N., 1993. Alzheimer-type neuropathology in elderly schizophrenia patients. Schizophr. Bull. 19, 805-816.
16. Soininen, H.S., Riekkinen, P.J., 1996. Apolipoprotein E, memory and Alzheimer's disease. Trends Neurosci. 19, 224-228.
17. Strittmatter, W.J., Saunders, A.M., Schmechel, D., Pericak-Vance, M., Enghild, J., Salvesen, G.S., Roses, A.D., 1993. Apolipoprotein E: high avidity binding to B amyloid and increased frequency of type 4 allele in late onset familial Alzheimer's disease. Proc. Natl. Acad. Sci. U.S.A. 90, 1977-1981.
18. Wechsler, D., 1981. Wechsler Adult Intelligence Scale-Revised. The Psychological Corporation, New York.
19. Wechsler, D., 1987. Wechsler Memory Scale-Revised. The Psychological Corporation, New York.
20. Wisniewski, H.M., Constantinidis, J., Wegiel, J., Bobinski, M., Tarnawski, M., 1994. Neurofibrillary pathology in brains of elderly schizophrenics treated with neuroleptics. Alz. Dis. Assoc. Disord. 8, 211-227.
21. Zhu, S., Noethen, M.M., Uhlhaas, S., Rietschel, M., Koerner, J., Lanczik, M., Fimmers, R., Propping, P., 1996. Apolipoprotein E genotype distribution in schizophrenia. Psychiatr. Genet. 6, 75-79.